Iconic Geneticist Evelyn Witkin Dies at Age 102

Lasker Award winner Evelyn Witkin discovered the mechanism for DNA repair following UV damage.

Written byLisa Winter
| 3 min read
An older woman wearing a blue suit, shaking hands with an older man wearing a black suit.
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Many cancer treatments and genetic therapies rely on a cell’s ability to repair damaged DNA. The mechanism behind this SOS response was discovered by geneticist Evelyn Witkin, who died on July 8 at the age of 102 at a rehabilitation facility following a fall.

Born March 9, 1921 in New York City, Evelyn Witkin, née Maisel, was the daughter of a pharmacist and homemaker. Her father died when she was 3 years old, according to an interview Witkin gave PLOS Genetics in 2012.1 At her stepfather’s behest, she attended a prestigious all girls school and accelerated through it, graduating at 16.

See “Lasker Winners Announced

Witkin attended New York University to study zoology and had intended to stay for graduate school, but her political advocacy changed that. She was one of the primary protest organizers who disagreed with the university’s policy to bench Black athletes during games against segregated Southern schools in the throes of the Jim Crow era. Ultimately, she was suspended in her senior year, pushing her graduation into the summer. Her prospects at NYU had dried up, so she went to Columbia University for her doctoral studies instead.

“Everything good that has happened to me professionally since then is a result of having being bounced out of college in my senior year,” Witkin said in a 2000 interview.2

At Columbia University, Witkin met the legendary evolutionary biologist Theodosius Dobzhansky and became his first female graduate student. Although Witkin hadn’t previously taken microbiology courses, Dobzhansky fostered her interests and encouraged her to seek professional opportunities at Cold Spring Harbor Laboratory (CSHL) in the summer.

Continue reading below...

Like this story? Sign up for FREE Genetics updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

In the summer of 1944 at CSHL, Witkin irradiated E. coli with UV light and found that while many of the colonies died, a few survived against all odds. She surmised that the survivors must have acquired mutations that protected them from the high dose of radiation. Witkin isolated those mutated colonies and started investigating how the bacteria detected genetic damage and worked around it.

This began a line of study that lasted several decades and eventually determined which genes are necessary for DNA repair and how the cell coordinated that response. Witkin’s work allowed researchers to better understand how mutagenesis works in cancer, leading them to identify targets for treatment.

In 1945, Witkin returned to CSHL to complete her thesis, then stayed on as a staff member until 1955. She later joined the staff of Brooklyn’s Downstate Medical Center, part of State University of New York, until 1971 when she became a professor at Rutgers University, where she stayed until the end of her career. Witkin was forced to retire in 1991 due to Rutgers’ mandatory retirement policy for staff at 70 years of age.

See “Damage Control

Witkin received many accolades throughout her career. She was elected into the National Academy of Sciences in 1977, the American Academy of Arts and Sciences in 1978, and the American Association for the Advancement of Science in 1980. In 2002, then-President George W. Bush presented her with the National Medal of Science. She shared the 2015 Lasker Award for Basic Medical Research with Stephen Elledge “for discoveries concerning the DNA-damage response—a fundamental mechanism that protects the genomes of all living organisms.” She was also awarded the Wiley Prize that same year. In recognition of her 100th birthday in 2021, the Waksman Institute at Rutgers University honored Witkin by naming a laboratory after her.3

She is preceded in death by her husband Herman and son Andrew. She is survived by her son John, along with many grandchildren and great-grandchildren.

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies